Simplified quantification of nicotinic receptors with 2[ 18F]F-A-85380 PET

Nuclear Medicine and Biology

Volumn 32, Issue 6, 2005, Pages 585-591

  Mitkovski, Sascha ^a   Villemagne, Victor L ^a,b,c   Novakovic, Kathy E ^a,c   O'Keefe, Graeme ^a   Tochon Danguy, Henri ^a   Mulligan, Rachel S ^a   Dickinson, Kerryn L ^a   Saunder, Tim ^a   Gregoire, Marie Claude ^d   Bottlaender, Michel ^d   Dolle, Frederic ^d   Rowe, Christopher C ^a,c,e  

^a AUSTIN HOSPITAL   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d DIF   (France)

^e AUSTIN HEALTH   (Australia)

Author keywords

2 18F F A 85380; Alzheimer's disease; Brain imaging; Neurodegenerative disorders; Nicotinic acetylcholine receptors; Positron emission tomography

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE F 18; NICOTINIC RECEPTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BINDING ASSAY; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HUMAN; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; STANDARDIZATION; STEADY STATE;

AZETIDINES; BLOOD SPECIMEN COLLECTION; BRAIN; BRAIN MAPPING; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KINETICS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTORS, NICOTINIC; TISSUE DISTRIBUTION;

EID: 22144483377     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.04.013     Document Type: Article

References (50)

1. J. Lindstrom, R. Anand, X. Peng, V. Gerzanich, F. Wang, and Y. Li Neuronal nicotinic receptor subtypes Ann N Y Acad Sci 757 1995 100 116
2. D. Paterson, and A. Nordberg Neuronal nicotinic receptors in the human brain Prog Neurobiol 61 1 2000 75 111
3. 3H]epibatidine Brain Res 801 1-2 1998 143 149
4. 125I]-alpha-bungarotoxin J Neurosci 5 5 1985 1307 1315
5. J.A. Court, C. Martin-Ruiz, A. Graham, and E. Perry Nicotinic receptors in human brain: topography and pathology J Chem Neuroanat 20 3-4 2000 281 298
6. E.K. Perry, C.M. Martin-Ruiz, and J.A. Court Nicotinic receptor subtypes in human brain related to aging and dementia Alcohol 24 2 2001 63 68
7. S. Hefft, S. Hulo, D. Bertrand, and D. Muller Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices J Physiol 515 Pt 3 1999 769 776
8. C. Lena, J.P. Changeux, and C. Mulle Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus J Neurosci 13 6 1993 2680 2688
9. K.L. Summers, and E. Giacobini Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex Neurochem Res 20 6 1995 753 759
10. S. Wonnacott Presynaptic nicotinic ACh receptors Trends Neurosci 20 2 1997 92 98
11. A. Nordberg Neuroreceptor changes in Alzheimer disease Cerebrovasc Brain Metab Rev 4 4 1992 303 328
12. A. Nordberg, I. Alafuzoff, and B. Winblad Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia J Neurosci Res 31 1 1992 103 111
13. P.J. Whitehouse, A.M. Martino, P.G. Antuono, P.R. Lowenstein, J.T. Coyle, and D.L. Price Nicotinic acetylcholine binding sites in Alzheimer's disease Brain Res 371 1 1986 146 151
14. P.J. Whitehouse Cholinergic therapy in dementia Acta Neurol Scand Suppl 149 1993 42 45
15. J. Lemiere, D. Van Gool, and R. Dom Treatment of Alzheimer's disease: an evaluation of the cholinergic approach Acta Neurol Belg 99 2 1999 96 106
16. M. Villarroya, A.G. Garcia, and J.L. Marco New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease Curr Pharm Des 10 25 2004 3177 3184
17. M. Quik, and J.M. Kulak Nicotine and nicotinic receptors; relevance to Parkinson's disease Neurotoxicology 23 4-5 2002 581 594
18. O.K. Steinlein, J.C. Mulley, P. Propping, R.H. Wallace, H.A. Phillips, and G.R. Sutherland A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy Nat Genet 11 2 1995 201 203
19. R. Freedman, M. Hall, L.E. Adler, and S. Leonard Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia Biol Psychiatry 38 1 1995 22 33
20. P.R. Sanberg, A.A. Silver, R.D. Shytle, M.K. Philipp, D.W. Cahill, and H.M. Fogelson Nicotine for the treatment of Tourette's syndrome Pharmacol Ther 74 1 1997 21 25
21. M.W. Decker, J.D. Brioni, J.P. Sullivan, M.J. Buckley, R.J. Radek, and J.L. Raszkiewicz (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization J Pharmacol Exp Ther 270 1 1994 319 328
22. L.S. Covey, A.H. Glassman, and F. Stetner Major depression following smoking cessation Am J Psychiatry 154 2 1997 263 265
23. N.L. Benowitz Pharmacology of nicotine: addiction and therapeutics Annu Rev Pharmacol Toxicol 36 1996 597 613
24. 11C-nicotine binding in normal and Alzheimer brains - in vivo assessment using positron emission tomography Alzheimer Dis Assoc Disord 9 1 1995 21 27
25. 11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo Psychopharmacology (Berl) 115 1-2 1994 31 36
26. B. Badio, and J.W. Daly Epibatidine, a potent analgetic and nicotinic agonist Mol Pharmacol 45 4 1994 563 569
27. V.L. Villemagne, A. Horti, U. Scheffel, H.T. Ravert, P. Finley, and D.J. Clough Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog J Nucl Med 38 11 1997 1737 1741
28. P.E. Molina, Y.S. Ding, F.I. Carroll, F. Liang, N.D. Volkow, and N. Pappas Fluoro-norchloroepibatidine: preclinical assessment of acute toxicity Nucl Med Biol 24 8 1997 743 747
29. J.P. Sullivan, D. Donnelly-Roberts, C.A. Briggs, D.J. Anderson, M. Gopalakrishnan, and M. Piattoni-Kaplan A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand Neuropharmacology 35 6 1996 725 734
30. 18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors Nucl Med Biol 25 7 1998 599 603
31. F. Dollé, L. Dolci, H. Valette, F. Hinnen, F. Vaufrey, and I. Guenther Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors J Med Chem 42 12 1999 2251 2259
32. 18F]fluoro-3-[2(S) -2-azetidinylmethoxy]pyridine in vivo Life Sci 64 5 1999 PL93 PL97
33. 18F-fluoro-A- 85380 in healthy volunteers J Nucl Med 44 4 2003 596 601
34. 18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans FASEB J 17 10 2003 1331 1333
35. 18F-Fluoro-A-85380 and PET J Nucl Med 46 2005 240 247
36. A.G. Horti, and V.L. Villemagne The Quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain Curr Pharm Des 2005 [in press]
37. P.E. Kinahan, and J.G. Rogers Analytic 3D image reconstruction using all detected events IEEE Trans Nucl Sci 36 1989 964 968
38. K.J. Friston, C.D. Frith, P.F. Liddle, and R.S. Frackowiak Comparing functional (PET) images: the assessment of significant change J Cereb Blood Flow Metab 11 1991 690 699
39. 11C-methyl]-(-)-cocaine PET studies in human subjects J Cereb Blood Flow Metab 10 1990 740 747
40. 18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain Synapse 48 1 2003 25 34
41. C. Gotti, D. Fornasari, and F. Clementi Human neuronal nicotinic receptors Prog Neurobiol 53 2 1997 199 237
42. L.M. Marubio, M. del Mar Arroyo-Jimenez, M. Cordero-Erausquin, C. Lena, N. Le Novere, and A. de Kerchove d'Exaerde Reduced antinociception in mice lacking neuronal nicotinic receptor subunits Nature 398 6730 1999 805 810
43. V.L. Villemagne, J. Musachio, and U. Scheffel Nicotinic compounds as PET and SPECT ligands S.P. Arneric J.D. Brioni Neuronal nicotinic receptors: pharmacology and therapeutic opportunities 1998 Wiley New York 235 250
44. 18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter Synapse 53 3 2004 184 189
45. A.S. Kimes, S. Chefer, J.A. Matochik, O. Pavlova, C. Contoreggi, and A. Horti PET quantitation of nicotinic receptors in the human brain NeuroImage 22 Suppl 2 2004 T79 T80
46. S.L. Pimlott, M. Piggott, J. Owens, E. Greally, J.A. Court, and E. Jaros Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380 Neuropsychopharmacology 29 1 2004 108 116
47. L.C. Gahring, K. Persiyanov, D. Dunn, R. Weiss, E.L. Meyer, and S.W. Rogers Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus J Comp Neurol 468 3 2004 334 346
48. L.C. Gahring, K. Persiyanov, and S.W. Rogers Neuronal and astrocyte expression of nicotinic receptor subunit beta4 in the adult mouse brain J Comp Neurol 468 3 2004 322 333
49. E.D. London, M.J. Ball, and S.B. Waller Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia Neurochem Res 14 8 1989 745 750
50. E.K. Perry, C.M. Morris, J.A. Court, A. Cheng, A.F. Fairbairn, and I.G. McKeith Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology Neuroscience 64 2 1995 385 395